CALC

CALCIMEDICA INC

• TipRanks·10/16 21:21

  CalciMedica Announces CFO Resignation and Leadership Transition

• TipRanks·09/30 20:33

  CalciMedica Establishes $25 Million ATM Stock Program

• TipRanks·09/16 20:38

  CalciMedica Regains Nasdaq Compliance, Listing Status Stabilized

• TipRanks·09/02 12:47

  CalciMedica Addresses Nasdaq Equity Compliance Amid Bid-Price Risk

• NASDAQ·08/27 18:13

  CalciMedica Announces 1-for-5 Reverse Stock Split

• Seeking Alpha·08/27 13:28

  CalciMedica announces 1-for-5 reverse stock split; shares down

• TipRanks·08/27 13:16

  CalciMedica to effect 1-for-5 reverse stock split

• Dow Jones·08/27 13:01

  *CalciMedica: Split Intended to Bring Co Into Compliance With Minimum Bid Price Requirement for Continued Listing on Nasdaq Cap Market >CALC

• Dow Jones·08/20 13:22

  CalciMedica Price Target Announced at $9.00/Share by Guggenheim

• TipRanks·08/20 10:32

  CalciMedica Shareholders Approve Key Equity and Governance Changes

• TipRanks·08/20 09:15

  CalciMedica initiated with a Buy at Guggenheim

• TipRanks·08/12 17:00

  Analysts Offer Insights on Healthcare Companies: NextCure (NXTC) and CalciMedica (CALC)

• Seeking Alpha·08/11 11:32

  CalciMedica GAAP EPS of -$0.45 misses by $0.16

• Dow Jones·08/11 11:00

  Press Release: CalciMedica Reports Second Quarter 2026 Financial Results and Provides Clinical & Corporate Updates

• TipRanks·07/29 14:40

  CalciMedica announces FDA alignment on Phase 2b Auxora trial design